Reports Outline Chondrosarcoma Research from Beijing Chaoyang Hospital (RNF2 promotes chondrosarcoma progression by regulating ubiquitination and degradation of CBX7).

Researchers at Beijing Chaoyang Hospital conducted a study on chondrosarcoma, a type of cancer resistant to traditional treatments. The study focused on the role of RNF2 and CBX7 in chondrosarcoma progression, finding that RNF2 promotes the degradation of CBX7 through ubiquitination, leading to tumor growth and metastasis. This research aims to develop targeted drugs for chondrosarcoma treatment. The study was funded by various organizations and published in Cancer & Metabolism. [Extracted from the article]